# Juluca

NDC: 49702-242
Generic name: dolutegravir sodium and rilpivirine hydrochloride
Labeler / Manufacturer: ViiV Healthcare Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20171121

FDA application: NDA210192

## Active ingredients

- DOLUTEGRAVIR SODIUM: 50 mg/1
- RILPIVIRINE HYDROCHLORIDE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49702-242"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-242
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=806653d1-bf35-4924-b999-ad5d21821cc1